The pancreatic cancer samples had significantly higher proportions of positive RON expression (195 of 227 patients, 85.9%) and MET expression (207 of 227 patients, 91.2%) compared with the normal/benign pancreatic tissue samples (5 of 20 patients, 25%). Here, MET is linked to familial pancreatic carcinoma.